Related Experiment Videos
Defective NK cell activation in X-linked lymphoproliferative disease.
1Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver Hospital and Health Sciences Centre, Canada.
Journal of Immunology (Baltimore, Md. : 1950)
|October 18, 2000
Summary
X-linked lymphoproliferative disease (XLP) involves immune deficiency due to mutations in signaling lymphocytic activation molecule-associated protein (SAP). This study reveals SAP mutations impair natural killer (NK) cell function, impacting XLP immune dysfunction.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- X-linked lymphoproliferative disease (XLP) is an immune deficiency primarily affecting EBV response.
- The molecular basis of XLP is linked to mutations in signaling lymphocytic activation molecule-associated protein (SAP).
- SAP is an intracellular molecule crucial for lymphocyte-activating surface receptors SLAM and 2B4.
Purpose of the Study:
- To investigate the impact of a specific SAP mutation on NK cell function in XLP patients.
- To determine the role of SAP-2B4 interaction in NK and lymphokine-activated killer (LAK) cell cytotoxicity.
Main Methods:
- Genetic analysis to identify a single nucleotide mutation in SAP.
- Assessment of NK and LAK cell cytotoxicity in XLP patients and normal controls.
- Evaluation of NK cell response to 2B4 receptor ligation.
Main Results:
- A single nucleotide mutation in SAP was identified, affecting NK cell function in affected males.
- XLP patients exhibited significantly reduced NK and LAK cell cytotoxicity compared to controls.
- While 2B4 ligation enhanced NK cell function in controls, it failed to do so in XLP patients.
Conclusions:
- The association of SAP with 2B4 is essential for optimal NK/LAK cell cytotoxicity.
- Alterations in SAP/2B4 signaling pathways contribute to the immune dysfunction characteristic of XLP.